H.I.G. Capital Makes Strategic Equity Investment in Rising Pharmaceuticals

December 13, 2021

An affiliate of H.I.G. Capital has made a strategic equity investment in Rising Pharma Holdings and Casper Pharma (together, Rising Pharmaceuticals) to support the company's growth, M&A activity and new product launches. Rising Pharmaceuticals is an asset-light developer and marketer of generic and specialty pharmaceuticals based in New Jersey with a diversified portfolio of over 125 products and a network of 23+ CMO/CDO partners.

Targets
Rising Pharma Holdings, Casper Pharma
Industry
Pharmaceuticals
Location
New Jersey, United States
Transaction Type
Growth capital

Explore More

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.